Total submissions: 3
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Counsyl | RCV000665124 | SCV000789190 | likely pathogenic | Autosomal recessive polycystic kidney disease | 2017-01-25 | criteria provided, single submitter | clinical testing | |
| Women's Health and Genetics/Laboratory Corporation of America, |
RCV000665124 | SCV003844984 | likely pathogenic | Autosomal recessive polycystic kidney disease | 2023-02-19 | criteria provided, single submitter | clinical testing | Variant summary: PKHD1 c.1095G>A (p.Trp365X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant was absent in 251306 control chromosomes (gnomAD). c.1095G>A has been reported in the literature in at-least one individual affected with Polycystic Kidney And Hepatic Disease (example: Denamur_2010). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as likely pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic. |
| Baylor Genetics | RCV004568489 | SCV005056300 | pathogenic | Polycystic kidney disease 4 | 2024-03-02 | criteria provided, single submitter | clinical testing |